RxGen to Present Alzheimer’s Disease APP/Abeta Cellular and Animal Models at the Society for Neuroscience’s 49th Annual Meeting

Click here to view original web page at www.globenewswire.com

NEW HAVEN, Conn., Oct. 14, 2019 (GLOBE NEWSWIRE) — RxGen, a preclinical translational research company, will be presenting a poster highlighting its progress in advancing preclinical models of Alzheimer’s disease (AD) to better predict clinical outcomes during the Society for Neuroscience (SfN) 49 th Annual Meeting in Chicago from […]